TY  - GEN
AU  - Chan,Shingpan
AU  - Han,Kun
AU  - Qu,Rong
AU  - Tong,Linjiang
AU  - Li,Yingjun
AU  - Zhang,Zhang
AU  - Cheng,Huimin
AU  - Lu,Xiaoyun
AU  - Patterson,Adam
AU  - Smaill,Jeff
AU  - Ren,Xiaomei
AU  - Ding,Jian
AU  - Xie,Hua
AU  - Ding,Ke
TI  - 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M)
SN  - 1464-3405
PY  - 2016///0524
KW  - Antineoplastic Agents
KW  - chemical synthesis
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Dose-Response Relationship, Drug
KW  - Drug Screening Assays, Antitumor
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Humans
KW  - Models, Molecular
KW  - Molecular Structure
KW  - Protein Kinase Inhibitors
KW  - Receptor, IGF Type 1
KW  - Receptors, Somatomedin
KW  - Structure-Activity Relationship
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.bmcl.2015.07.089
ER  -